{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T22:15:47Z","timestamp":1768083347023,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.pan.2012.02.013","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T17:30:43Z","timestamp":1376587843000},"page":"146-155","source":"Crossref","is-referenced-by-count":22,"title":["HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA)"],"prefix":"10.1016","volume":"12","author":[{"given":"Oua\u00efssi","family":"Mehdi","sequence":"first","affiliation":[]},{"given":"Silvy","family":"Fran\u00e7oise","sequence":"additional","affiliation":[]},{"given":"Costa Lima","family":"Sofia","sequence":"additional","affiliation":[]},{"given":"Giger","family":"Urs","sequence":"additional","affiliation":[]},{"given":"Zemmour","family":"Kevin","sequence":"additional","affiliation":[]},{"given":"Sastre","family":"Bernard","sequence":"additional","affiliation":[]},{"given":"Sielezneff","family":"Igor","sequence":"additional","affiliation":[]},{"given":"Cordeiro-da-Silva","family":"Anabela","sequence":"additional","affiliation":[]},{"given":"Lombardo","family":"Dominique","sequence":"additional","affiliation":[]},{"given":"Mas","family":"Eric","sequence":"additional","affiliation":[]},{"given":"Oua\u00efssi","family":"Ali","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"issue":"50","key":"10.1016\/j.pan.2012.02.013_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.50.1.7","article-title":"Cancer statistics","volume":"2000","author":"Greenlee","year":"2000","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.pan.2012.02.013_bib2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2165\/00003495-200059050-00004","article-title":"Pancreatic cancer: a review of emerging therapies","volume":"59","author":"Rosenberg","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.pan.2012.02.013_bib3","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2012.02.013_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/path.1418","article-title":"Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of s100 genes is highly prevalent","volume":"201","author":"Crnogorac-Jurcevic","year":"2003","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pan.2012.02.013_bib5","first-page":"8614","article-title":"Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies","volume":"63","author":"Iacobuzio-Donahue","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2012.02.013_bib6","first-page":"2649","article-title":"Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer","volume":"63","author":"Logsdon","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2012.02.013_bib7","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1593\/neo.04295","article-title":"Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays","volume":"6","author":"Grutzmann","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.pan.2012.02.013_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7","article-title":"Histone deacetylases, transcriptional control, and cancer","volume":"184","author":"Cress","year":"2000","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.pan.2012.02.013_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00001622-200111000-00010","article-title":"Histone deacetylase inhibitors as new cancer drugs","volume":"13","author":"Marks","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.pan.2012.02.013_bib10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/PL00000896","article-title":"Histone acetylation and disease","volume":"58","author":"Timmermann","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pan.2012.02.013_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3727\/000000001783992687","article-title":"Role of histone acetylation in the assembly and modulation of chromatin structures","volume":"9","author":"Annunziato","year":"2000","journal-title":"Gene Expr"},{"key":"10.1016\/j.pan.2012.02.013_bib12","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1349-7006.2001.tb02153.x","article-title":"Expression profile of histone deacetylase 1 in gastric cancer tissues","volume":"92","author":"Choi","year":"2001","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.pan.2012.02.013_bib13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1535-6108(04)00114-X","article-title":"Induction of hdac2 expression upon loss of apc in colorectal tumorigenesis","volume":"5","author":"Zhu","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.pan.2012.02.013_bib14","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1074\/jbc.M510023200","article-title":"Histone deacetylase 3 (hdac3) and other class i hdacs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer","volume":"281","author":"Wilson","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pan.2012.02.013_bib15","first-page":"4041","article-title":"Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets","volume":"62","author":"Scanlan","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2012.02.013_bib16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjc.6600156","article-title":"Isolation of a sir-like gene, sir-t8, that is overexpressed in thyroid carcinoma cell lines and tissues","volume":"86","author":"de Nigris","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pan.2012.02.013_bib17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bbrc.2003.08.029","article-title":"Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of sirt2 gene","volume":"309","author":"Hiratsuka","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pan.2012.02.013_bib18","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1245\/s10434-008-9940-z","article-title":"High histone deacetylase 7 (hdac7) expression is significantly associated with adenocarcinomas of the pancreas","volume":"15","author":"Ouaissi","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pan.2012.02.013_bib19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1124\/mol.105.014167","article-title":"Rational development of histone deacetylase inhibitors as anticancer agents: a review","volume":"68","author":"Acharya","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pan.2012.02.013_bib20","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1158\/1078-0432.CCR-06-0511","article-title":"A\u00a0phase i study of intravenous lbh589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies","volume":"12","author":"Giles","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pan.2012.02.013_bib21","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.3748\/wjg.14.3681","article-title":"Experimental treatment of pancreatic cancer with two novel histone deacetylase inhibitors","volume":"14","author":"Haefner","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2012.02.013_bib22","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0002-9440(10)64800-6","article-title":"Immortal human pancreatic duct epithelial cell lines with near normal genotype and phenotype","volume":"157","author":"Ouyang","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pan.2012.02.013_bib23","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1158\/0008-5472.CAN-04-3208","article-title":"In\u00a0vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by k-ras oncogenic activation in pancreatic carcinogenesis","volume":"65","author":"Qian","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2012.02.013_bib24","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4161\/cbt.7.4.5480","article-title":"Histone deacetylase (hdac) encoding gene expression in pancreatic cancer cell lines and cell sensitivity to hdac inhibitors","volume":"7","author":"Ouaissi","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.pan.2012.02.013_bib25","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/carcin\/bgm159","article-title":"Ras\/erk modulates tgfbeta-regulated pten expression in human pancreatic adenocarcinoma cells","volume":"28","author":"Chow","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pan.2012.02.013_bib26","first-page":"1763","article-title":"Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the e6e7 gene of human papilloma virus 16","volume":"148","author":"Furukawa","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pan.2012.02.013_bib27","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s004280100474","article-title":"Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of k-ras, p53, p16 and dpc4\/smad4","volume":"439","author":"Moore","year":"2001","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pan.2012.02.013_bib28","first-page":"31","article-title":"Establishment and characterization of human pancreatic adenocarcinoma cell line soj producing carcinoembryonic antigen and carbohydrate antigen 19-9]","volume":"3","author":"Fujii","year":"1990","journal-title":"Hum Cell"},{"key":"10.1016\/j.pan.2012.02.013_bib29","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1093\/nar\/16.22.10881","article-title":"Multiple sequence alignment with hierarchical clustering","volume":"16","author":"Corpet","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.pan.2012.02.013_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A\u00a0rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.pan.2012.02.013_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A\u00a0novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin v","volume":"184","author":"Vermes","year":"1995","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.pan.2012.02.013_bib32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0006-3495(99)77214-0","article-title":"Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives","volume":"76","author":"Scaduto","year":"1999","journal-title":"Biophys J"},{"key":"10.1016\/j.pan.2012.02.013_bib33","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1007\/s11095-010-0268-6","article-title":"In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer","volume":"27","author":"Hoskins","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.pan.2012.02.013_bib34","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","article-title":"Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase iii trial of the National Cancer Institute of Canada Clinical Trials Group","volume":"25","author":"Moore","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2012.02.013_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11912-007-0018-z","article-title":"Pancreatic cancer: an update","volume":"9","author":"Kindler","year":"2007","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.pan.2012.02.013_bib36","first-page":"S16","article-title":"Targeted therapies for pancreatic cancer","volume":"2","author":"Philip","year":"2008","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.pan.2012.02.013_bib37","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbrc.2006.07.185","article-title":"Histone deacetylase inhibitor trichostatin a and proteasome inhibitor ps-341 synergistically induce apoptosis in pancreatic cancer cells","volume":"348","author":"Bai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pan.2012.02.013_bib38","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/nrc949","article-title":"Pancreatic cancer biology and genetics","volume":"2","author":"Bardeesy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pan.2012.02.013_bib39","first-page":"13474","article-title":"Histone deacetylase enzymes as potential drug targets in cancer and parasitic diseases","volume":"2006","author":"Ouaissi","year":"2006","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.pan.2012.02.013_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/mc.10145","article-title":"Trichostatin a, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells","volume":"38","author":"Donadelli","year":"2003","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.pan.2012.02.013_bib41","doi-asserted-by":"crossref","unstructured":"Shao W, Growney JD, Feng Y, O'Connor G, Pu M, Zhu W, et\u00a0al: Activity of deacetylase inhibitor panobinostat (lbh589) in cutaneous t-cell lymphoma models: defining molecular mechanisms of resistance. Int J Cancer. 127:2199\u20132208.","DOI":"10.1002\/ijc.25218"},{"key":"10.1016\/j.pan.2012.02.013_bib42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.canlet.2009.02.019","article-title":"Development of the pan-dac inhibitor panobinostat (lbh589): successes and challenges","volume":"280","author":"Atadja","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pan.2012.02.013_bib43","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1158\/0008-5472.CAN-05-4186","article-title":"The histone deacetylase inhibitor lbh589 is a potent antimyeloma agent that overcomes drug resistance","volume":"66","author":"Maiso","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2012.02.013_bib44","first-page":"6068","article-title":"Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21waf1\/cip1 and gelsolin","volume":"60","author":"Han","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2012.02.013_bib45","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s00018-003-3090-z","article-title":"Differential regulation of the sir2 histone deacetylase gene family by inhibitors of class i and ii histone deacetylases","volume":"60","author":"Kyrylenko","year":"2003","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pan.2012.02.013_bib46","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390312000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390312000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T22:17:54Z","timestamp":1563661074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390312000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1424390312000464"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2012.02.013","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}